← Back to all trials
Completed
NCT05661994
Omega-3 Supplementation on Serum Fetuin-A Levels
Conditions: Coronary Artery Disease
Sex: Male
Ages: 35 Years – 75 Years
Phase: NA
Enrollment: 34
Sponsor: Amasya University
Location: Turkey
Summary
Background and aims: One of the investigated possible modulators of serum fetuin-A, associated with the risk of developing coronary artery disease (CAD), is omega-3 fatty acids (FAs).
This study aims to evaluate the effects of omega-3 FA supplementation on serum fetuin-A concentration in patients with CAD.Methods: The study was carried out on 34 male volunteer patients aged 35-75 years, newly diagnosed with CAD by conventional coronary angiography.
Patients with CAD were divided into the "Omega-3 Group (n:16)" and "Control Group (n:18)".
Low-fat diet principles were explained to both groups at baseline.
While 1.560 mg/day omega-3 FA supplementation was given to the patients in the omega-3 group for eight weeks, but not in the control group.
Food intake was recorded using six-day food records.
Eligibility Criteria
Inclusion Criteria:Male volunteer patients aged 35-75 yearsPatients with newly diagnosed with coronary artery disease by conventional coronary angiographyExclusion Criteria:Individuals who have dieted in the last six monthsUse of omega-3 fatty acid and/or vitamin/mineral supplements or statin group drugsBMI <18.5 and ≥40 kg/m2Fasting blood glucose ≥ 126 mg/dLPresence of systemic diseases such as Type 1 and Type 2 diabetes, kidney diseases, liver diseases, cancer or neurological diseasesActive athletes and/or those who exercise regularly
Source: ClinicalTrials.gov (NCT05661994). StuddyBuddy aggregates publicly available trial information.
